Max network transcriptional repressor (MNT)

Max network transcriptional repressor (MNT) is a transcription factor that is an essential component of the Myc/Max/Mad network, contributing primarily through transcriptional repression[1][2][3][7]. MNT contains a basic helix-loop-helix-zipper (bHLHzip) domain that mediates heterodimerization with MAX and binding to the E-box DNA consensus sequence, enabling repression of genes that promote cell growth and proliferation. MNT acts as a major antagonist of Myc-driven transcriptional activation, opposing Myc–MAX complexes to ensure appropriate cellular growth, differentiation, and survival. MNT recruits the Sin3 corepressor complex via its N-terminal Sin3-interaction domain, resulting in transcriptional silencing through chromatin remodeling activities[1][2][5]. Dysregulation of MNT has diverse effects on cellular signaling and disease, particularly in tumorigenesis, where loss of function enhances Myc activity and promotes oncogenesis[2][4]. MNT levels are dynamically regulated in response to cellular stress and developmental cues, maintaining critical balance in cell fate decisions[2][4]. No drugs are currently available that directly target MNT, and its modulation carries potential risks for normal cell regulation.

Other names

Max-binding protein MNTMAD6MXD6ROXbHLHd3myc antagonist MNTMax-interacting proteinclass D basic helix-loop-helix protein 3MNT gene productProtein ROX

Drugs targeting this molecule would, in theory, modulate gene expression by inhibiting or enhancing its transcriptional repressor activity via interactions with DNA or protein partners such as MAX or SIN3A. No specific drugs are known to interact directly with MNT[3][7].